NewGenIVF Group (NIVF) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$4.6M

Revenue (quarter)

$1.9M

Revenue growth (year over year)

−4.69%

Gross profit (trailing twelve months)

$1.1M

Gross margin

23.89%

Net income (trailing twelve months)

$951,299.00

Net income (quarter)

−$8.1M

Net income growth (year over year)

−1257.45%

Net margin

20.54%

Return on equity

6.27%

EPS (trailing twelve months)

$487.17

Book value per share

$23.61

P/E (trailing twelve months)

1.56

Price to book

0.07

Debt to assets

29.43%

Payout ratio

—

Dividend yield

—

Company profile

NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.

• Is NewGenIVF Group (NIVF) profitable?

  Yes. NewGenIVF Group earned $951,299.00 in net income over the trailing twelve months, a net margin of 20.54%.

• How much revenue does NewGenIVF Group (NIVF) make?

  NewGenIVF Group generated $4.6M in revenue over the trailing twelve months, down 4.69% year over year.

• What is NIVF's P/E ratio?

  NewGenIVF Group trades at 1.6 times trailing twelve-month earnings, on an EPS of $487.17.

• How do I buy stock in NewGenIVF Group (NIVF)?

  NIVF trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.